Viewing Study NCT05579366


Ignite Creation Date: 2025-12-24 @ 4:14 PM
Ignite Modification Date: 2025-12-25 @ 8:43 PM
Study NCT ID: NCT05579366
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2022-10-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor: Genmab
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module